Cargando…

Control of occult hepatitis B virus infection

BACKGROUND: The diagnosis of hepatitis B virus (HBV) infection requires HBV DNA testing and serologic testing for detection of the surface antigen (HBsAg) and the hepatitis B core antibody (anti-HBc). There is a population of patients with occult HBV infection (OBI), which is not detected by HBsAg o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalana Garcés, Marta, Ortiz Pastor, Oihana, Solé Enrech, Gemma, Guerra-Ruiz, Armando R., Casals Mercadal, Gregori, Almería Lafuente, Alejandro, Ballesteros Vizoso, María Antonieta, Medina, Pablo Gabriel, Salgüero Fernández, Sergio, Zamora Trillo, Angielys, Aured de la Serna, Isabel, Hurtado, Juan Carlos, Pérez-Del-Pulgar, Sofía, Forns, Xavier, Morales Ruiz, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197267/
https://www.ncbi.nlm.nih.gov/pubmed/37363431
http://dx.doi.org/10.1515/almed-2022-0065
Descripción
Sumario:BACKGROUND: The diagnosis of hepatitis B virus (HBV) infection requires HBV DNA testing and serologic testing for detection of the surface antigen (HBsAg) and the hepatitis B core antibody (anti-HBc). There is a population of patients with occult HBV infection (OBI), which is not detected by HBsAg or HBV DNA quantification in blood, despite the presence of active replication in the liver. SCOPE: This document provides a definition of OBI and describes the diagnostic techniques currently used. It also addresses the detection of patients with risk factors and the need for screening for OBI in these patients. SUMMARY: Correct diagnosis of OBI prevents HBV reactivation and transmission. Diagnosis of OBI is based on the detection of HBV DNA in patients with undetectable HBsAg in blood. PERSPECTIVES: A high number of patients with OBI may remain undiagnosed; therefore, screening for OBI in patients with factor risks is essential. For a correct diagnosis of OBI, it is necessary that new markers such as ultrasensitive HBsAg are incorporated, and a more comprehensive marker study is performed by including markers such as cccDNA.